Emerging technologies for the clinical microbiology laboratory

Clinical Microbiology Reviews

Volumn 27, Issue 4, 2014, Pages 783-822

  Buchan, Blake W ^a   Ledeboer, Nathan A ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; RNA POLYMERASE;

ARTICLE; CLINICAL LABORATORY; ELECTROSPRAY; ENGINEERING AND TECHNOLOGY; HELICASE DEPENDENT AMPLIFICATION; HUMAN; LABORATORY AUTOMATION; LOOP MEDIATED ISOTHERMAL AMPLIFICATION; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICROARRAY ANALYSIS; MICROBIAL IDENTIFICATION; MICROBIOLOGY; MOLECULAR DIAGNOSTICS; MULTIPLEX POLYMERASE CHAIN REACTION; NEXT GENERATION SEQUENCING; NONHUMAN; NUCLEIC ACID AMPLIFICATION; NUCLEIC ACID AMPLIFICATION TESTING; NUCLEIC ACID ANALYSIS; QUANTITATIVE ANALYSIS; SANGER SEQUENCING; SEQUENCE ANALYSIS; TRANSCRIPTION MEDIATED AMPLIFICATION; GENETIC PROCEDURES; MASS SPECTROMETRY; MICROBIOLOGICAL EXAMINATION; PROCEDURES; STANDARDS;

AUTOMATION, LABORATORY; GENETIC TECHNIQUES; HUMANS; MASS SPECTROMETRY; MICROBIOLOGICAL TECHNIQUES;

EID: 84907798849     PISSN: 08938512     EISSN: 10986618     Source Type: Journal    
DOI: 10.1128/CMR.00003-14     Document Type: Article

References (261)

1. Hodinka RL. 2013. Point: is the era of viral culture over in the clinical microbiology laboratory? J. Clin. Microbiol. 51:2–4. http://dx.doi.org/10.1128/JCM.02593-12.
2. Clark AE, Kaleta EJ, Arora A, Wolk DM. 2013. Matrix-assisted laser desorption ionization-time of flight mass spectrometry: a fundamental shift in the routine practice of clinical microbiology. Clin. Microbiol. Rev. 26:547–603. http://dx.doi.org/10.1128/CMR.00072-12.
3. Burd EM. 2010. Validation of laboratory-developed molecular assays for infectious diseases. Clin. Microbiol. Rev. 23:550–576. http://dx.doi.org/10.1128/CMR.00074-09.
4. Valenstein PN. 1990. Evaluating diagnostic tests with imperfect standards. Am. J. Clin. Pathol. 93:252–258.
5. CLSI. 2005. User varification of performance for precisioin and true-ness. Approved guideline, 2nd ed. CLSI document EP15-A2. CLSI, Wayne, PA.
6. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA. 1988. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487–491. http://dx.doi.org/10.1126/science.2448875.
7. Mackay IM, Arden KE, Nitsche A. 2002. Real-time PCR in virology. Nucleic Acids Res. 30:1292–1305. http://dx.doi.org/10.1093/nar/30.6.1292.
8. Monif GR. 1998. A new gold standard for the detection of Chlamydia trachomatis? Infect. Dis. Obstet. Gynecol. 6:44–45. http://dx.doi.org/10.1155/S106474499800009X.
9. Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, Pepin J, Wilcox MH. 2010. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect. Control Hosp. Epidemiol. 31:431–455. http://dx.doi.org/10.1086/651706.
10. Ieven M. 2007. Currently used nucleic acid amplification tests for the detection of viruses and atypicals in acute respiratory infections. J. Clin. Virol. 40:259–276. http://dx.doi.org/10.1016/j.jcv.2007.08.012.
11. Giachetti C, Linnen JM, Kolk DP, Dockter J, Gillotte-Taylor K, Park M, Ho-Sing-Loy M, McCormick MK, Mimms LT, McDonough SH. 2002. Highly sensitive multiplex assay for detection of human immunodeficiency virus type 1 and hepatitis C virus RNA. J. Clin. Microbiol. 40:2408–2419. http://dx.doi.org/10.1128/JCM.40.7.2408-2419.2002.
12. Wroblewski JK, Manhart LE, Dickey KA, Hudspeth MK, Totten PA. 2006. Comparison of transcription-mediated amplification and PCR assay results for various genital specimen types for detection of Myco-plasma genitalium. J. Clin. Microbiol. 44:3306–3312. http://dx.doi.org/10.1128/JCM.00553-06.
13. Gaydos CA, Quinn TC, Willis D, Weissfeld A, Hook EW, Martin DH, Ferrero DV, Schachter J. 2003. Performance of the APTIMA Combo 2 assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in female urine and endocervical swab specimens. J. Clin. Microbiol. 41:304–309. http://dx.doi.org/10.1128/JCM.41.1.304-309.2003.
14. Martin DH, Cammarata C, Van Der Pol B, Jones RB, Quinn TC, Gaydos CA, Crotchfelt K, Schachter J, Moncada J, Jungkind D, Turner B, Peyton C. 2000. Multicenter evaluation of AMPLICOR and automated COBAS AMPLICOR CT/NG tests for Neisseria gonorrhoeae. J. Clin. Microbiol. 38:3544–3549.
15. Van Der Pol B, Quinn TC, Gaydos CA, Crotchfelt K, Schachter J, Moncada J, Jungkind D, Martin DH, Turner B, Peyton C, Jones RB. 2000. Multicenter evaluation of the AMPLICOR and automated COBAS AMPLICOR CT/NG tests for detection ofChlamydia trachomatis.J. Clin. Microbiol. 38:1105–1112.
16. Van Der Pol B, Liesenfeld O, Williams JA, Taylor SN, Lillis RA, Body BA, Nye M, Eisenhut C, Hook EW, III. 2012. Performance of the Cobas CT/NG test compared to the Aptima AC2 and Viper CTQ/GCQ assays for detection ofChlamydia trachomatisandNeisseria gonorrhoeae.J.Clin. Microbiol. 50:2244–2249. http://dx.doi.org/10.1128/JCM.06481-11.
17. Mushanski LM, Brandt K, Coffin N, Levett PN, Horsman GB, Rank EL. 2012. Comparison of the BD Viper System with XTR Technology to the Gen-Probe APTIMA COMBO2Assay using the TIGRIS DTS system for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine specimens. Sex. Transm. Dis. 39:514–517. http://dx.doi.org/10.1097/OLQ.0b013e31824f2f5b.
18. Stewart CM, Schoeman SA, Booth RA, Smith SD, Wilcox MH, Wilson JD. 2012. Assessment of self taken swabs versus clinician taken swab cultures for diagnosing gonorrhoea in women: single centre, diagnostic accuracy study. BMJ 345:e8107. http://dx.doi.org/10.1136/bmj.e8107.
19. Van Der Pol B, Taylor SN, Liesenfeld O, Williams JA, Hook EW, III. 2013. Vaginal swabs are the optimal specimen for detection of genital Chlamydia trachomatis or Neisseria gonorrhoeae using the Cobas 4800 CT/NG test. Sex. Transm. Dis. 40:247–250. http://dx.doi.org/10.1097/OLQ.0b013e3182717833.
20. Huang SS, Septimus E, Kleinman K, Moody J, Hickok J, Avery TR, Lankiewicz J, Gombosev A, Terpstra L, Hartford F, Hayden MK, Jernigan JA, Weinstein RA, Fraser VJ, Haffenreffer K, Cui E, Kaganov RE, Lolans K, Perlin JB, Platt R. 2013. Targeted versus universal decolonization to prevent ICU infection. N. Engl. J. Med. 368:2255–2265. http://dx.doi.org/10.1056/NEJMoa1207290.
21. Pofahl WE, Ramsey KM, Nobles DL, Cochran MK, Goettler C. 2011. Importance of methicillin-resistant Staphylococcus aureus eradication in carriers to prevent postoperative methicillin-resistant Staphylococcus au-reus surgical site infection. Am. Surg. 77:27–31.
22. Jog S, Cunningham R, Cooper S, Wallis M, Marchbank A, Vasco-Knight P, Jenks PJ. 2008. Impact of preoperative screening for meticil-lin-resistant Staphylococcus aureus by real-time polymerase chain reaction in patients undergoing cardiac surgery. J. Hosp. Infect. 69:124–130. http://dx.doi.org/10.1016/j.jhin.2008.02.008.
23. Lee BY, Wiringa AE, Bailey RR, Goyal V, Tsui B, Lewis GJ, Muder RR, Harrison LH. 2010. The economic effect of screening orthopedic surgery patients preoperatively for methicillin-resistant Staphylococcus aureus. Infect. Control Hosp. Epidemiol. 31:1130–1138. http://dx.doi.org/10.1086/656591.
24. Brecher SM, Novak-Weekley SM, Nagy E. 2013. Laboratory diagnosis of Clostridium difficile infections: there is light at the end of the colon. Clin. Infect. Dis. 57:1175–1181. http://dx.doi.org/10.1093/cid/cit424.
25. Peterson LR, Mehta MS, Patel PA, Hacek DM, Harazin M, Nagwekar PP, Thomson RB, Robicsek A. 2011. Laboratory testing for Clostrid-ium difficile infection: light at the end of the tunnel. Am. J. Clin. Pathol. 136:372–380. http://dx.doi.org/10.1309/AJCPTP5XKRSNXVIL.
26. Wilcox MH. 2012. Overcoming barriers to effective recognition and diagnosis of Clostridium difficile infection. Clin. Microbiol. Infect. 18(Suppl 6):S13–S20.
27. Crobach MJ, Dekkers OM, Wilcox MH, Kuijper EJ. 2009. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): data review and recommendations for diagnosing Clostridium difficile-infection (CDI). Clin. Microbiol. Infect. 15:1053–1066. http://dx.doi.org/10.1111/j.1469-0691.2009.03098.x.
28. Longtin Y, Trottier S, Brochu G, Paquet-Bolduc B, Garenc C, Loung-narath V, Beaulieu C, Goulet D, Longtin J. 2013. Impact of the type of diagnostic assay on Clostridium difficile infection and complication rates in a mandatory reporting program. Clin. Infect. Dis. 56:67–73. http://dx.doi.org/10.1093/cid/cis840.
29. Sethi AK, Al-Nassir WN, Nerandzic MM, Bobulsky GS, Donskey CJ. 2010. Persistence of skin contamination and environmental shedding of Clostridium difficile during and after treatment of C. difficile infection. Infect. Control Hosp. Epidemiol. 31:21–27. http://dx.doi.org/10.1086/649016.
30. Dubberke ER, Han Z, Bobo L, Hink T, Lawrence B, Copper S, Hoppe-Bauer J, Burnham CA, Dunne WM, Jr. 2011. Impact of clinical symptoms on interpretation of diagnostic assays for Clostridium difficile infections. J. Clin. Microbiol. 49:2887–2893. http://dx.doi.org/10.1128/JCM.00891-11.
31. Burnham CA, Carroll KC. 2013. Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories. Clin. Microbiol. Rev. 26:604–630. http://dx.doi.org/10.1128/CMR.00016-13.
32. CDC. 2007. Outbreaks of respiratory illness mistakenly attributed to pertussis—New Hampshire, Massachusetts, and Tennessee, 2004-2006. MMWR Morb. Mortal. Wkly. Rep. 56:837–842.
33. Waters V, Jamieson F, Richardson SE, Finkelstein M, Wormsbecker A, Halperin SA. 2009. Outbreak of atypical pertussis detected by polymerase chain reaction in immunized preschool-aged children. Pediatr. Infect. Dis. J. 28:582–587. http://dx.doi.org/10.1097/INF.0b013e318197fac1.
34. Papenburg J, Fontela P. 2009. What is the significance of a high cycle threshold positive IS481 PCR for Bordetella pertussis? Pediatr. Infect. Dis. J. 28:1143. (Author reply, 28:1143–1144.)
35. Guthrie JL, Seah C, Brown S, Tang P, Jamieson F, Drews SJ. 2008. Use of Bordetella pertussis BP3385 to establish a cutoff value for an IS481-targeted real-time PCR assay. J.Clin. Microbiol. 46:3798–3799. http://dx.doi.org/10.1128/JCM.01551-08.
36. Notomi T, Okayama H, Masubuchi H, Yonekawa T, Watanabe K, Amino N, Hase T. 2000. Loop-mediated isothermal amplification of DNA. Nucleic Acids Res. 28:E63. http://dx.doi.org/10.1093/nar/28.12.e63.
37. Mori Y, Nagamine K, Tomita N, Notomi T. 2001. Detection of loop-mediated isothermal amplification reaction by turbidity derived from magnesium pyrophosphate formation. Biochem. Biophys. Res. Com-mun. 289:150–154. http://dx.doi.org/10.1006/bbrc.2001.5921.
38. Mori Y, Kitao M, Tomita N, Notomi T. 2004. Real-time turbidimetry of LAMP reaction for quantifying template DNA. J. Biochem. Biophys. Methods 59:145–157. http://dx.doi.org/10.1016/j.jbbm.2003.12.005.
39. Anderson NW, Buchan BW, Mayne D, Mortensen JE, Mackey TL, Ledeboer NA. 2013. Multicenter clinical evaluation of the illumigene group A Streptococcus DNA amplification assay for detection of group A Streptococcus from pharyngeal swabs. J. Clin. Microbiol. 51:1474–1477. http://dx.doi.org/10.1128/JCM.00176-13.
40. Gyorke CE, Wang S, Leslie JL, Cohen SH, Solnick JV, Polage CR. 2013. Evaluation of Clostridium difficile fecal load and limit of detection during a prospective comparison of two molecular tests, the illumigene C. difficile and Xpert C. difficile/Epi tests. J. Clin. Microbiol. 51:278–280. http://dx.doi.org/10.1128/JCM.02120-12.
41. Viala C, Le Monnier A, Maataoui N, Rousseau C, Collignon A, Poilane I. 2012. Comparison of commercial molecular assays for toxigenic Clos-tridium difficile detection in stools: BD GeneOhm Cdiff, XPert C. difficile and illumigene C. difficile. J. Microbiol. Methods 90:83–85. http://dx.doi.org/10.1016/j.mimet.2012.04.017.
42. Pancholi P, Kelly C, Raczkowski M, Balada-Llasat JM. 2012. Detection of toxigenic Clostridium difficile: comparison of the cell culture neutralization, Xpert C. difficile, Xpert C. difficile/Epi, and Illumigene C. difficile assays. J. Clin. Microbiol. 50:1331–1335. http://dx.doi.org/10.1128/JCM.06597-11.
43. Buchan BW, Mackey TL, Daly JA, Alger G, Denys GA, Peterson LR, Kehl SC, Ledeboer NA. 2012. Multicenter clinical evaluation of the portrait toxigenic C. difficile assay for detection of toxigenic Clostridium difficile strains in clinical stool specimens. J. Clin. Microbiol. 50:3932–3936. http://dx.doi.org/10.1128/JCM.02083-12.
44. Henson AM, Carter D, Todd K, Shulman ST, Zheng X. 2013. Detection of Streptococcus pyogenes using illumigene group A Streptococcus assay. J. Clin. Microbiol. 51:4207–4209. http://dx.doi.org/10.1128/JCM.01892-13.
45. Karani M, Sotiriadou I, Plutzer J, Karanis P. 2014. Bench-scale experiments for the development of a unified loop-mediated isothermal amplification (LAMP) assay for the in vitro diagnosis of Leishmania species’ promastigotes. Epidemiol. Infect. 142:1671–1677. http://dx.doi.org/10.1017/S0950268813002677.
46. Kargar M, Askari A, Doosti A, Ghorbani-Dalini S. 2012. Loop-mediated isothermal amplification assay for rapid detection of hepatitis C virus. Indian J. Virol. 23:18–23. http://dx.doi.org/10.1007/s13337-012 -0067-2.
47. Plutzer J, Karanis P. 2009. Rapid identification of Giardia duodenalis by loop-mediated isothermal amplification (LAMP) from faecal and environmental samples and comparative findings by PCR and real-time PCR methods. Parasitol. Res. 104:1527–1533. http://dx.doi.org/10.1007/s00436-009-1391-3.
48. Ablordey A, Amissah DA, Aboagye IF, Hatano B, Yamazaki T, Sata T, Ishikawa K, Katano H. 2012. Detection of Mycobacterium ulcerans by the loop mediated isothermal amplification method. PLoS Negl. Trop. Diseases. 6:e1590. http://dx.doi.org/10.1371/journal.pntd.0001590.
49. Hopkins H, Gonzalez IJ, Polley SD, Angutoko P, Ategeka J, Asiimwe C, Agaba B, Kyabayinze DJ, Sutherland CJ, Perkins MD, Bell D. 2013. Highly sensitive detection of malaria parasitemia in a malaria-endemic setting: performance of a new loop-mediated isothermal amplification kitinaremote clinicin Uganda. J.Infect. Dis. 208:645–652. http://dx.doi.org/10.1093/infdis/jit184.
50. Polley SD, Gonzalez IJ, Mohamed D, Daly R, Bowers K, Watson J, Mewse E, Armstrong M, Gray C, Perkins MD, Bell D, Kanda H, Tomita N, Kubota Y, Mori Y, Chiodini PL, Sutherland CJ. 2013. Clinical evaluation of a loop-mediated amplification kit for diagnosis of imported malaria. J. Infect. Dis. 208:637–644. http://dx.doi.org/10.1093/infdis/jit183.
51. Poon LL, Wong BW, Ma EH, Chan KH, Chow LM, Abeyewickreme W, Tangpukdee N, Yuen KY, Guan Y, Looareesuwan S, Peiris JS. 2006. Sensitive and inexpensive molecular test for falciparum malaria: detecting Plasmodium falciparum DNA directly from heat-treated blood by loop-mediated isothermal amplification. Clin. Chem. 52:303–306. http://dx.doi.org/10.1373/clinchem.2005.057901.
52. Han ET, Watanabe R, Sattabongkot J, Khuntirat B, Sirichaisinthop J, Iriko H, Jin L, Takeo S, Tsuboi T. 2007. Detection of four Plasmodium species by genus- and species-specific loop-mediated isothermal amplification for clinical diagnosis. J. Clin. Microbiol. 45:2521–2528. http://dx.doi.org/10.1128/JCM.02117-06.
53. Vincent M, Xu Y, Kong H. 2004. Helicase-dependent isothermal DNA amplification. EMBO Rep. 5:795–800. http://dx.doi.org/10.1038/sj.embor.7400200.
54. Huang S, Do J, Mahalanabis M, Fan A, Zhao L, Jepeal L, Singh SK, Klapperich CM. 2013. Low cost extraction and isothermal amplification of DNA for infectious diarrhea diagnosis. PLoS One 8:e60059. http://dx.doi.org/10.1371/journal.pone.0060059.
55. Frech GC, Munns D, Jenison RD, Hicke BJ. 2012. Direct detection of nasal Staphylococcus aureus carriage via helicase-dependent isothermal amplification and chip hybridization. BMC Res. Notes 5:430. http://dx.doi.org/10.1186/1756-0500-5-430.
56. Li Y, Kumar N, Gopalakrishnan A, Ginocchio C, Manji R, Bythrow M, Lemieux B, Kong H. 2013. Detection and species identification of malaria parasites by isothermal tHDA amplification directly from human blood without sample preparation. J. Mol. Diagn. 15:634–641. http://dx.doi.org/10.1016/j.jmoldx.2013.05.005.
57. Miller NS, Yen-Lieberman B, Poulter MD, Tang YW, Granato PA. 2012. Comparative clinical evaluation of the IsoAmp HSV Assay with ELVIS HSV culture/ID/typing test system for the detection of herpes simplex virus in genital and oral lesions. J. Clin. Virol. 54:355–358. http://dx.doi.org/10.1016/j.jcv.2012.04.004.
58. Artiushin S, Tong Y, Timoney J, Lemieux B, Schlegel A, Kong H. 2011. Thermophilic helicase-dependent DNA amplification using the IsoAmp SE experimental kit for rapid detection of Streptococcus equi subspecies equi in clinical samples. J. Vet. Diagn. Invest. 23:909–914. http://dx.doi.org/10.1177/1040638711416968.
59. Kim HJ, Tong Y, Tang W, Quimson L, Cope VA, Pan X, Motre A, Kong R, Hong J, Kohn D, Miller NS, Poulter MD, Kong H, Tang YW, Yen-Lieberman B. 2011. A rapid and simple isothermal nucleic acid amplification test for detection of herpes simplex virus types 1 and 2. J. Clin. Virol. 50:26–30. http://dx.doi.org/10.1016/j.jcv.2010.09.006.
60. Robinson A, Marcon M, Mortensen JE, McCarter YS, LaRocco M, Peterson LR, Thomson RB. 1999. Controversies affecting the future practice of clinical microbiology. J. Clin. Microbiol. 37:883–889.
61. Ho C, Lau A, Cimon K, Farrah K, Gardam M. 2013. Screening, isolation, and decolonization strategies for vancomycin-resistant entero-cocci or extended spectrum beta-lactamase-producing organisms: a systematic review of the clinical evidence and health services impact. CADTH Technol. Overviews 3:e3202.
62. Bauer KA, West JE, Balada-Llasat JM, Pancholi P, Stevenson KB, Goff DA. 2010. An antimicrobial stewardship program’s impact with rapid polymerase chain reaction methicillin-resistant Staphylococcus aureus/S. aureus blood culture test in patients with S. aureus bacteremia. Clin. Infect. Dis. 51:1074–1080. http://dx.doi.org/10.1086/656623.
63. Frye AM, Baker CA, Rustvold DL, Heath KA, Hunt J, Leggett JE, Oethinger M. 2012. Clinical impact of a real-time PCR assay for rapid identification of staphylococcal bacteremia. J. Clin. Microbiol. 50:127–133. http://dx.doi.org/10.1128/JCM.06169-11.
64. Luo RF, Banaei N. 2013. Molecular approaches and biomarkers for detection of Mycobacterium tuberculosis. Clin. Lab. Med. 33:553–566. http://dx.doi.org/10.1016/j.cll.2013.03.012.
65. Millman AJ, Dowdy DW, Miller CR, Brownell R, Metcalfe JZ, Catta-manchi A, Davis JL. 2013. Rapid molecular testing for TB to guide respiratory isolation in the U.S.: a cost-benefit analysis. PLoS One 8:e79669. http://dx.doi.org/10.1371/journal.pone.0079669.
66. Marks SM, Cronin W, Venkatappa T, Maltas G, Chon S, Sharnprapai S, Gaeddert M, Tapia J, Dorman SE, Etkind S, Crosby C, Blumberg HM, Bernardo J. 2013. The health-system benefits and cost-effectiveness of using Mycobacterium tuberculosis direct nucleic acid amplification testing to diagnose tuberculosis disease in the United States. Clin. Infect. Dis. 57:532–542. http://dx.doi.org/10.1093/cid/cit336.
67. Davis JL, Kawamura LM, Chaisson LH, Grinsdale J, Benhammou J, Ho C, Babst A, Banouvong H, Metcalfe JZ, Pandori M, Hopewell PC, Cattamanchi A. 2014. Impact of GeneXpert MTB/RIF on patients and tuberculosis programs in a low-burden setting: a hypothetical trial. Am. J. Respir. Crit. Care Med. 189:1551–1559. http://dx.doi.org/10.1164/rccm.201311-1974OC.
68. Chamberlain JS, Gibbs RA, Ranier JE, Nguyen PN, Caskey CT. 1988. Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification. Nucleic Acids Res. 16:11141–11156. http://dx.doi.org/10.1093/nar/16.23.11141.
69. Landry ML, Cohen S, Ferguson D. 2000. Impact of sample type on rapid detection of influenza virus A by cytospin-enhanced immunofluores-cence and membrane enzyme-linked immunosorbent assay. J. Clin. Mi-crobiol. 38:429–430.
70. Boivin G, Cote S, Dery P, De Serres G, Bergeron MG. 2004. Multiplex real-time PCR assay for detection of influenza and human respiratory syncytial viruses. J. Clin. Microbiol. 42:45–51. http://dx.doi.org/10.1128/JCM.42.1.45-51.2004.
71. Sails AD, Saunders D, Airs S, Roberts D, Eltringham G, Magee JG. 2009. Evaluation of the Cepheid respiratory syncytial virus and influenza virus A/B real-time PCR analyte specific reagent. J. Virol. Methods 162: 88–90. http://dx.doi.org/10.1016/j.jviromet.2009.07.020.
72. Buelow DR, Bankowski MJ, Fofana D, Gu Z, Pounds S, Hayden RT. 2013. Comparison of two multiplexed PCR assays for the detection of HSV-1, HSV-2, and VZV with extracted and unextracted cutaneous and mucosal specimens. J. Clin. Virol. 58:84–88. http://dx.doi.org/10.1016/j.jcv.2013.05.008.
73. Buchan BW, Olson WJ, Pezewski M, Marcon MJ, Novicki T, Uphoff TS, Chandramohan L, Revell P, Ledeboer NA. 2013. Clinical evaluation of a real-time PCR assay for identification of Salmonella, Shigella, Campylobacter (Campylobacter jejuni and C. coli), and Shiga toxin-producing Escherichia coli isolates in stool specimens. J. Clin. Microbiol. 51:4001-4007. http://dx.doi.org/10.1128/JCM.02056-13.
74. Snyder JW, Munier GK, Heckman SA, Camp P, Overman TL. 2009. Failure of the BD GeneOhm StaphSR assay for direct detection of methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolates in positive blood cultures collected in the United States. J. Clin. Microbiol. 47:3747–3748. http://dx.doi.org/10.1128/JCM.01391-09.
75. Westh H, Lisby G, Breysse F, Boddinghaus B, Chomarat M, Gant V, Goglio A, Raglio A, Schuster H, Stuber F, Wissing H, Hoeft A. 2009. Multiplex real-time PCR and blood culture for identification of bloodstream pathogens in patients with suspected sepsis. Clin. Microbiol. Infect. 15:544–551. http://dx.doi.org/10.1111/j.1469-0691.2009.02736.x.
76. Bloos F, Hinder F, Becker K, Sachse S, Mekontso Dessap A, Straube E, Cattoir V, Brun-Buisson C, Reinhart K, Peters G, Bauer M. 2010. A multicenter trial to compare blood culture with polymerase chain reaction in severe human sepsis. Intensive Care Med. 36:241–247. http://dx.doi.org/10.1007/s00134-009-1705-z.
77. Casalta JP, Gouriet F, Roux V, Thuny F, Habib G, Raoult D. 2009. Evaluation of the LightCycler SeptiFast test in the rapid etiologic diagnostic of infectious endocarditis. Eur. J. Clin. Microbiol. Infect. Dis. 28: 569–573. http://dx.doi.org/10.1007/s10096-008-0672-6.
78. Stamper PD, Cai M, Howard T, Speser S, Carroll KC. 2007. Clinical validation of the molecular BD GeneOhm StaphSR assay for direct detection of Staphylococcus aureus and methicillin-resistant Staphylococcus aureus in positive blood cultures. J. Clin. Microbiol. 45:2191–2196. http://dx.doi.org/10.1128/JCM.00552-07.
79. Bartels MD, Boye K, Rohde SM, Larsen AR, Torfs H, Bouchy P, Skov R, Westh H. 2009. A common variant of staphylococcal cassette chromosome mec type IVa in isolates from Copenhagen, Denmark, is not detected by the BD GeneOhm methicillin-resistant Staphylococcus aureus assay. J. Clin. Microbiol. 47:1524–1527. http://dx.doi.org/10.1128/JCM.02153-08.
80. Thomas L, van Hal S, O’Sullivan M, Kyme P, Iredell J. 2008. Failure of the BD GeneOhm StaphS/R assay for identification of Australian methicillin-resistant Staphylococcus aureus strains: duplex assays as the “gold standard” in settings of unknown SCCmec epidemiology. J. Clin. Microbiol. 46:4116–4117. http://dx.doi.org/10.1128/JCM.01146-08.
81. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Ed-mond MB. 2004. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 39:309–317. http://dx.doi.org/10.1086/421946.
82. Poritz MA, Blaschke AJ, Byington CL, Meyers L, Nilsson K, Jones DE, Thatcher SA, Robbins T, Lingenfelter B, Amiott E, Herbener A, Daly J, Dobrowolski SF, Teng DH, Ririe KM. 2011. FilmArray, an automated nested multiplex PCR system for multi-pathogen detection: development and application to respiratory tract infection. PLoS One 6:e26047. http://dx.doi.org/10.1371/journal.pone.0026047.
83. Van Wesenbeeck L, Meeuws H, Van Immerseel A, Ispas G, Schmidt K, Houspie L, Van Ranst M, Stuyver L. 2013. Comparison of the FilmArray RP, Verigene RV+, and Prodesse ProFLU+/FAST+ multiplex platforms for detection of influenza viruses in clinical samples from the 2011-2012 influenza season in Belgium. J. Clin. Microbiol. 51:2977–2985. http://dx.doi.org/10.1128/JCM.00911-13.
84. Pierce VM, Elkan M, Leet M, McGowan KL, Hodinka RL. 2012. Comparison of the Idaho Technology FilmArray system to real-time PCR for detection of respiratory pathogens in children. J. Clin. Microbiol. 50:364–371. http://dx.doi.org/10.1128/JCM.05996-11.
85. Altun O, Almuhayawi M, Ullberg M, Ozenci V. 2013. Clinical evaluation of the FilmArray blood culture identification panel in identification of bacteria and yeasts from positive blood culture bottles. J. Clin. Microbiol. 51:4130–4136. http://dx.doi.org/10.1128/JCM.01835-13.
86. Babady NE. 2013. The FilmArray respiratory panel: an automated, broadly multiplexed molecular test for the rapid and accurate detection of respiratory pathogens. Expert Rev. Mol. Diagn. 13:779–788. http://dx.doi.org/10.1586/14737159.2013.848794.
87. Popowitch EB, O’Neill SS, Miller MB. 2013. Comparison of the Biofire FilmArray RP, Genmark eSensor RVP, Luminex xTAG RVPv1, and Lu-minex xTAG RVP fast multiplex assays for detection of respiratory viruses. J. Clin. Microbiol. 51:1528–1533. http://dx.doi.org/10.1128/JCM.03368-12.
88. Piralla A, Lunghi G, Percivalle E, Vigano C, Nasta T, Pugni L, Mosca F, Stronati M, Torresani E, Baldanti F. 2014. FilmArray respiratory panel performance in respiratory samples from neonatal care units. Di-agn. Microbiol. Infect. Dis. 79:183–186. http://dx.doi.org/10.1016/j.diagmicrobio.2014.02.010.
89. Doern CD, Lacey D, Huang R, Haag C. 2013. Evaluation and implementation of FilmArray version 1.7 for improved detection of adenovi-rus respiratory tract infection. J. Clin. Microbiol. 51:4036–4039. http://dx.doi.org/10.1128/JCM.02546-13.
90. Blaschke AJ, Heyrend C, Byington CL, Fisher MA, Barker E, Garrone NF, Thatcher SA, Pavia AT, Barney T, Alger GD, Daly JA, Ririe KM, Ota I, Poritz MA. 2012. Rapid identification of pathogens from positive blood cultures by multiplex polymerase chain reaction using the FilmArray system. Diagn. Microbiol. Infect. Dis. 74:349–355. http://dx.doi.org/10.1016/j.diagmicrobio.2012.08.013.
91. Protonotariou E, Dimitroulia E, Pournaras S, Pitiriga V, Sofianou D, Tsakris A. 2010. Trends in antimicrobial resistance of clinical isolates of Enterococcus faecalis and Enterococcus faecium in Greece between 2002 and 2007. J. Hosp. Infect. 75:225–227. http://dx.doi.org/10.1016/j.jhin.2009.12.007.
92. Miller MB, Tang YW. 2009. Basic concepts of microarrays and potential applications in clinical microbiology. Clin. Microbiol. Rev. 22:611–633. http://dx.doi.org/10.1128/CMR.00019-09.
93. Hager J. 2006. Making and using spotted DNA microarrays in an academic core laboratory. Methods Enzymol. 410:135–168. http://dx.doi.org/10.1016/S0076-6879(06)10007-5.
94. Carroll KC, Buchan BW, Tan S, Stamper PD, Riebe KM, Pancholi P, Kelly C, Rao A, Fader R, Cavagnolo R, Watson W, Goering RV, Trevino EA, Weissfeld AS, Ledeboer NA. 2013. Multicenter evaluation of the Verigene Clostridium difficile nucleic acid assay. J. Clin. Microbiol. 51:4120–4125. http://dx.doi.org/10.1128/JCM.01690-13.
95. Wojewoda CM, Sercia L, Navas M, Tuohy M, Wilson D, Hall GS, Procop GW, Richter SS. 2013. Evaluation of the Verigene Gram-positive blood culture nucleic acid test for rapid detection of bacteria and resistance determinants. J. Clin. Microbiol. 51:2072–2076. http://dx.doi.org/10.1128/JCM.00831-13.
96. Samuel LP, Tibbetts RJ, Agotesku A, Fey M, Hensley R, Meier FA. 2013. Evaluation of a microarray-based assay for rapid identification of Gram-positive organisms and resistance markers in positive blood cultures. J. Clin. Microbiol. 51:1188–1192. http://dx.doi.org/10.1128/JCM.02982-12.
97. Buchan BW, Ginocchio CC, Manii R, Cavagnolo R, Pancholi P, Swyers L, Thomson RB, Jr., Anderson C, Kaul K, Ledeboer NA. 2013. Multiplex identification of gram-positive bacteria and resistance determinants directly from positive blood culture broths: evaluation of an automated microarray-based nucleic acid test. PLoS medicine. 10: e1001478. http://dx.doi.org/10.1371/journal.pmed.1001478.
98. Buchan BW, Peterson JF, Cogbill CH, Anderson DK, Ledford JS, White MN, Quigley NB, Jannetto PJ, Ledeboer NA. 2011. Evaluation of a microarray-based genotyping assay for the rapid detection of cyto-chrome P450 2C19 *2 and *3 polymorphisms from whole blood using nanoparticle probes. Am. J. Clin. Pathol. 136:604–608. http://dx.doi.org/10.1309/AJCPCPU9Q2IRNYXC.
99. Lefferts JA, Jannetto P, Tsongalis GJ. 2009. Evaluation of the Nano-sphere Verigene system and the Verigene F5/F2/MTHFR nucleic acid tests. Exp. Mol. Pathol. 87:105–108. http://dx.doi.org/10.1016/j.yexmp.2009.06.002.
100. Jannetto PJ, Buchan BW, Vaughan KA, Ledford JS, Anderson DK, Henley DC, Quigley NB, Ledeboer NA. 2010. Real-time detection of influenza A, influenza B, and respiratory syncytial virus A and B in respiratory specimens by use of nanoparticle probes. J. Clin. Microbiol. 48: 3997–4002. http://dx.doi.org/10.1128/JCM.01118-10.
101. Sullivan KV, Deburger B, Roundtree SS, Ventrola CA, Blecker-Shelly DL, Mortensen JE. 23 April 2014. Rapid detection of inpatient Gram-negative bacteremia; extended-spectrum beta-lactamases and carbapen-emase resistance determinants with the Verigene BC-GN test: a multi-center evaluation. J. Clin. Microbiol. http://dx.doi.org/10.1128/JCM.00737-14.
102. Tojo M, Fujita T, Ainoda Y, Nagamatsu M, Hayakawa K, Mezaki K, Sakurai A, Masui Y, Yazaki H, Takahashi H, Miyoshi-Akiyama T, Totsuka K, Kirikae T, Ohmagari N. 2014. Evaluation of an automated rapid diagnostic assay for detection of gram-negative bacteria and their drug-resistance genes in positive blood cultures. PLoS One 9:e94064. http://dx.doi.org/10.1371/journal.pone.0094064.
103. Alby K, Popowitch EB, Miller MB. 2013. Comparative evaluation of the Nanosphere Verigene RV+ assay and the Simplexa Flu A/B & RSV kit for detection of influenza and respiratory syncytial viruses. J. Clin. Microbiol. 51:352–353. http://dx.doi.org/10.1128/JCM.02504-12.
104. Boku S, Naito T, Murai K, Tanei M, Inui A, Nisimura H, Isonuma H, Takahashi H, Kikuchi K. 2013. Near point-of-care administration by the attending physician of the rapid influenza antigen detection immu-nochromatography test and the fully automated respiratory virus nucleic acid test: contribution to patient management. Diagn. Microbiol. Infect. Dis. 76:445–449. http://dx.doi.org/10.1016/j.diagmicrobio.2013.04.029.
105. Warny M, Pepin J, Fang A, Killgore G, Thompson A, Brazier J, Frost E, McDonald LC. 2005. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 366:1079–1084. http://dx.doi.org/10.1016/S0140-6736(05)67420-X.
106. See I, Mu Y, Cohen J, Beldavs ZG, Winston LG, Dumyati G, Holz-bauer S, Dunn J, Farley MM, Lyons C, Johnston H, Phipps E, Perl-mutter R, Anderson L, Gerding DN, Lessa FC. 2014. NAP1 strain type predicts outcomes from Clostridium difficile infection. Clin. Infect. Dis. 58:1394–1400. http://dx.doi.org/10.1093/cid/ciu125.
107. Mestas J, Polanco CM, Felsenstein S, Dien Bard J. 2014. Performance of the Verigene gram-positive blood culture assay for direct detection of Gram-positive organisms and resistance markers in a pediatric hospital. J. Clin. Microbiol. 52:283–287. http://dx.doi.org/10.1128/JCM.02322-13.
108. Beal SG, Ciurca J, Smith G, John J, Lee F, Doern CD, Gander RM. 2013. Evaluation of the nanosphere verigene gram-positive blood culture assay with the VersaTREK blood culture system and assessment of possible impact on selected patients. J. Clin. Microbiol. 51:3988–3992. http://dx.doi.org/10.1128/JCM.01889-13.
109. Sullivan KV, Turner NN, Roundtree SS, Young S, Brock-Haag CA, Lacey D, Abuzaid S, Blecker-Shelly DL, Doern CD. 2013. Rapid detection of Gram-positive organisms by use of the Verigene Gram-positive blood culture nucleic acid test and the BacT/Alert Pediatric FAN system in a multicenter pediatric evaluation. J. Clin. Microbiol. 51:3579–3584. http://dx.doi.org/10.1128/JCM.01224-13.
110. Merante F, Yaghoubian S, Janeczko R. 2007. Principles of the xTAG respiratory viral panel assay (RVP Assay). J. Clin. Virol. 40(Suppl 1):S31-S35. http://dx.doi.org/10.1016/S1386-6532(07)70007-0.
111. Claas EC, Burnham CA, Mazzulli T, Templeton K, Topin F. 2013. Performance of the xTAG(R) gastrointestinal pathogen panel, a multiplex molecular assay for simultaneous detection of bacterial, viral, and parasitic causes of infectious gastroenteritis. J. Microbiol. Biotechnol. 23:1041–1045. http://dx.doi.org/10.4014/jmb.1212.12042.
112. Mengelle C, Mansuy JM, Prere MF, Grouteau E, Claudet I, Kamar N, Huynh A, Plat G, Benard M, Marty N, Valentin A, Berry A, Izopet J. 2013. Simultaneous detection of gastrointestinal pathogens with a multiplex Luminex-based molecular assay in stool samples from diarrhoeic patients. Clin. Microbiol. Infect. 19:E458–E4565. http://dx.doi.org/10.1111/1469-0691.12255.
113. Pabbaraju K, Tokaryk KL, Wong S, Fox JD. 2008. Comparison of the Luminex xTAG respiratory viral panel with in-house nucleic acid amplification tests for diagnosis of respiratory virus infections. J. Clin. Microbiol. 46:3056–3062. http://dx.doi.org/10.1128/JCM.00878-08.
114. Anderson TP, Werno AM, Barratt K, Mahagamasekera P, Murdoch DR, Jennings LC. 2013. Comparison of four multiplex PCR assays for the detection of viral pathogens in respiratory specimens. J. Virol. Methods 191:118–121. http://dx.doi.org/10.1016/j.jviromet.2013.04.005.
115. Anonymous. 2004. Adenovirus. Am. J. Transplant. 4(Suppl 10):101-104. http://dx.doi.org/10.1111/j.1600-6135.2004.00733.x.
116. Shim JK, Johnson S, Samore MH, Bliss DZ, Gerding DN. 1998. Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea. Lancet 351:633–636. http://dx.doi.org/10.1016/S0140-6736(97)08062-8.
117. Alasmari F, Seiler SM, Hink T, Burnham CA, Dubberke ER. 2014. Prevalence and risk factors for asymptomatic Clostridium difficile carriage. Clin. Infect. Dis. 59:216–222. http://dx.doi.org/10.1093/cid/ciu258.
118. Forrest GN, Mehta S, Weekes E, Lincalis DP, Johnson JK, Venezia RA. 2006. Impact of rapid in situ hybridization testing on coagulase-negative staphylococci positive blood cultures. J. Antimicrob. Chemother. 58: 154–158. http://dx.doi.org/10.1093/jac/dkl146.
119. Forrest GN, Mankes K, Jabra-Rizk MA, Weekes E, Johnson JK, Lin-calis DP, Venezia RA. 2006. Peptide nucleic acid fluorescence in situ hybridization-based identification of Candida albicans and its impact on mortality and antifungal therapy costs. J. Clin. Microbiol. 44:3381–3383. http://dx.doi.org/10.1128/JCM.00751-06.
120. Forrest GN, Roghmann MC, Toombs LS, Johnson JK, Weekes E, Lincalis DP, Venezia RA. 2008. Peptide nucleic acid fluorescent in situ hybridization for hospital-acquired enterococcal bacteremia: delivering earlier effective antimicrobial therapy. Antimicrob. Agents Chemother. 52:3558–3563. http://dx.doi.org/10.1128/AAC.00283-08.
121. Spector SA, Hsia K, Crager M, Pilcher M, Cabral S, Stempien MJ. 1999. Cytomegalovirus (CMV) DNA load is anindependent predictor of CMV disease and survival in advanced AIDS. J. Virol. 73:7027–7030.
122. Emery VC, Sabin CA, Cope AV, Gor D, Hassan-Walker AF, Griffiths PD. 2000. Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation. Lancet 355:2032–2036. http://dx.doi.org/10.1016/S0140-6736(00)02350-3.
123. Bogdanovic G, Priftakis P, Giraud G, Kuzniar M, Ferraldeschi R, Kokhaei P, Mellstedt H, Remberger M, Ljungman P, Winiarski J, Dalianis T. 2004. Association between a high BK virus load in urine samples of patients with graft-versus-host disease and development of hemorrhagic cystitis after hematopoietic stem cell transplantation. J. Clin. Microbiol. 42:5394–5396. http://dx.doi.org/10.1128/JCM.42.11.5394-5396.2004.
124. Erard V, Kim HW, Corey L, Limaye A, Huang ML, Myerson D, Davis C, Boeckh M. 2005. BK DNA viral load in plasma: evidence for an association with hemorrhagic cystitis in allogeneic hematopoietic cell transplant recipients. Blood 106:1130–1132. http://dx.doi.org/10.1182/blood-2004-12-4988.
125. Korenromp EL, Williams BG, Schmid GP, Dye C. 2009. Clinical prognostic value ofRNA viral load and CD4 cell counts during untreated HIV-1 infection—a quantitative review. PLoS One 4:e5950. http://dx.doi.org/10.1371/journal.pone.0005950.
126. Lee SO, Brown RA, Razonable RR. 2012. Chromosomally integrated human herpesvirus-6 in transplant recipients. Transplant Infect. Dis. 14:346–354. http://dx.doi.org/10.1111/j.1399-3062.2011.00715.x.
127. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR. 2005. MicroRNA expression profiles classify human cancers. Nature 435:834–838. http://dx.doi.org/10.1038/nature03702.
128. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O’Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M. 2008. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. U. S. A. 105:10513–10518. http://dx.doi.org/10.1073/pnas.0804549105.
129. Van’t Veer LJ, Bernards R. 2008. Enabling personalized cancer medicine through analysis of gene-expression patterns. Nature 452:564–570. http://dx.doi.org/10.1038/nature06915.
130. Lievre A, Bachet JB, Boige V, Cayre A, Le Corre D, Buc E, Ychou M, Bouche O, Landi B, Louvet C, Andre T, Bibeau F, Diebold MD, Rougier P, Ducreux M, Tomasic G, Emile JF, Penault-Llorca F, Lau-rent-Puig P. 2008. KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab. J. Clin. Oncol. 26:374–379. http://dx.doi.org/10.1200/JCO.2007.12.5906.
131. Wong ML, Medrano JF. 2005. Real-time PCR for mRNA quantitation. Biotechniques 39:75–85. http://dx.doi.org/10.2144/05391RV01.
132. Versalovic J, Carroll K, Funke G, Jorgensen JH, Landry ML, Warnock DW (ed). 2011. Manual of clinical microbiology, 10th ed, vol 2. ASM Press, Washington, DC.
133. Boyle DL, Rosengren S, Bugbee W, Kavanaugh A, Firestein GS. 2003. Quantitative biomarker analysis of synovial gene expression by real-time PCR. Arthritis Res. Ther. 5:R352–R360. http://dx.doi.org/10.1186/ar1004.
134. Lai KK, Cook L, Wendt S, Corey L, Jerome KR. 2003. Evaluation of real-time PCR versus PCR with liquid-phase hybridization for detection of enterovirus RNA in cerebrospinal fluid. J. Clin. Microbiol. 41:3133–3141. http://dx.doi.org/10.1128/JCM.41.7.3133-3141.2003.
135. Boeckh M, Huang M, Ferrenberg J, Stevens-Ayers T, Stensland L, Nichols WG, Corey L. 2004. Optimization of quantitative detection of cytomegalovirus DNA in plasma by real-time PCR. J. Clin. Microbiol. 42:1142–1148. http://dx.doi.org/10.1128/JCM.42.3.1142-1148.2004.
136. Sedlak RH, Jerome KR. 2013. Viral diagnostics in the era of digital polymerase chain reaction. Diagn. Microbiol. Infect. Dis. 75:1–4. http://dx.doi.org/10.1016/j.diagmicrobio.2012.10.009.
137. Baker M. 2012. Digital PCR hits its stride. Nat. Methods 9:541–544. http://dx.doi.org/10.1038/nmeth.2027.
138. Hindson CM, Chevillet JR, Briggs HA, Gallichotte EN, Ruf IK, Hind-son BJ, Vessella RL, Tewari M. 2013. Absolute quantification by droplet digital PCR versus analog real-time PCR. Nat. Methods 10:1003–1005. http://dx.doi.org/10.1038/nmeth.2633.
139. Sykes PJ, Neoh SH, Brisco MJ, Hughes E, Condon J, Morley AA. 1992. Quantitation of targets for PCR by use of limiting dilution. Biotech-niques 13:444–449.
140. Ma J, Li N, Guarnera M, Jiang F. 2013. Quantification of plasma miRNAs by digital PCR for cancer diagnosis. Biomarker Insights 8:127–136. http://dx.doi.org/10.4137/BMI.S13154.
141. Ludwig JA, Weinstein JN. 2005. Biomarkers in cancer staging, prognosis and treatment selection. Nat. Rev. Cancer 5:845–856. http://dx.doi.org/10.1038/nrc1739.
142. Sawyers CL. 2008. The cancer biomarker problem. Nature 452:548–552. http://dx.doi.org/10.1038/nature06913.
143. Taly V, Pekin D, Benhaim L, Kotsopoulos SK, Le Corre D, Li X, Atochin I, Link DR, Griffiths AD, Pallier K, Blons H, Bouche O, Landi B, Hutchison JB, Laurent-Puig P. 2013. Multiplex picodroplet digital PCR to detect KRAS mutations in circulating DNA from the plasma of colorectal cancer patients. Clin. Chem. 59:1722–1731. http://dx.doi.org/10.1373/clinchem.2013.206359.
144. Kelley K, Cosman A, Belgrader P, Chapman B, Sullivan DC. 2013. Detection of methicillin-resistant Staphylococcus aureus by a duplex droplet digital PCR assay. J. Clin. Microbiol. 51:2033–2039. http://dx.doi.org/10.1128/JCM.00196-13.
145. Roberts CH, Last A, Molina-Gonzalez S, Cassama E, Butcher R, Nabicassa M, McCarthy E, Burr SE, Mabey DC, Bailey RL, Holland MJ. 2013. Development and evaluation of a next-generation digital PCR diagnostic assay for ocular Chlamydia trachomatis infections. J. Clin. Mi-crobiol. 51:2195–2203. http://dx.doi.org/10.1128/JCM.00622-13.
146. Strain MC, Lada SM, Luong T, Rought SE, Gianella S, Terry VH, Spina CA, Woelk CH, Richman DD. 2013. Highly precise measurement of HIV DNA by droplet digital PCR. PLoS One 8:e55943. http://dx.doi.org/10.1371/journal.pone.0055943.
147. Shen F, Sun B, Kreutz JE, Davydova EK, Du W, Reddy PL, Joseph LJ, Ismagilov RF. 2011. Multiplexed quantification of nucleic acids with large dynamic range using multivolume digital RT-PCR on a rotational SlipChip tested with HIV and hepatitis C viral load. J. Am. Chem. Soc. 133:17705–17712. http://dx.doi.org/10.1021/ja2060116.
148. Sedlak RH, Cook L, Huang ML, Magaret A, Zerr DM, Boeckh M, Jerome KR. 2014. Identification of chromosomally integrated human herpesvirus 6 by droplet digital PCR. Clin. Chem. 60:765–772. http://dx.doi.org/10.1373/clinchem.2013.217240.
149. Salipante SJ, Sengupta DJ, Rosenthal C, Costa G, Spangler J, Sims EH, Jacobs MA, Miller SI, Hoogestraat DR, Cookson BT, McCoy C, Matsen FA, Shendure J, Lee CC, Harkins TT, Hoffman NG. 2013. Rapid 16S rRNA next-generation sequencing of polymicrobial clinical samples for diagnosis of complex bacterial infections. PLoS One 8:e65226. http://dx.doi.org/10.1371/journal.pone.0065226.
150. Liu L, Li Y, Li S, Hu N, He Y, Pong R, Lin D, Lu L, Law M. 2012. Comparisonof next-generation sequencing systems. J. Biomed. Biotech-nol. 2012:251364. http://dx.doi.org/10.1155/2012/251364.
151. Nyren P. 1987. Enzymatic method for continuous monitoring of DNA polymerase activity. Anal. Biochem. 167:235–238. http://dx.doi.org/10.1016/0003-2697(87)90158-8.
152. Hyman ED. 1988. A new method of sequencing DNA. Anal. Biochem. 174:423–436. http://dx.doi.org/10.1016/0003-2697(88)90041-3.
153. Ronaghi M, Karamohamed S, Pettersson B, Uhlen M, Nyren P. 1996. Real-time DNA sequencing using detection of pyrophosphate release. Anal. Biochem. 242:84–89. http://dx.doi.org/10.1006/abio.1996.0432.
154. Wheeler DA, Srinivasan M, Egholm M, Shen Y, Chen L, McGuire A, He W, Chen YJ, Makhijani V, Roth GT, Gomes X, Tartaro K, Niazi F, Turcotte CL, Irzyk GP, Lupski JR, Chinault C, Song XZ, Liu Y, Yuan Y, Nazareth L, Qin X, Muzny DM, Margulies M, Weinstock GM, Gibbs RA, Rothberg JM. 2008. The complete genome of an individual by massively parallel DNA sequencing. Nature 452:872–876. http://dx.doi.org/10.1038/nature06884.
155. Mashayekhi F, Ronaghi M. 2007. Analysis of read length limiting factors in pyrosequencing chemistry. Anal. Biochem. 363:275–287. http://dx.doi.org/10.1016/j.ab.2007.02.002.
156. Huse SM, Huber JA, Morrison HG, Sogin ML, Welch DM. 2007. Accuracy and quality of massively parallel DNA pyrosequencing. Genome Biol. 8:R143. http://dx.doi.org/10.1186/gb-2007-8-7-r143.
157. Margulies M, Egholm M, Altman WE, Attiya S, Bader JS, Bemben LA, Berka J, Braverman MS, Chen YJ, Chen Z, Dewell SB, Du L, Fierro JM, Gomes XV, Godwin BC, He W, Helgesen S, Ho CH, Irzyk GP, Jando SC, Alenquer ML, Jarvie TP, Jirage KB, Kim JB, Knight JR, Lanza JR, Leamon JH, Lefkowitz SM, Lei M, Li J, Lohman KL, Lu H, Makhijani VB, McDade KE, McKenna MP, Myers EW, Nickerson E, Nobile JR, Plant R, Puc BP, Ronan MT, Roth GT, Sarkis GJ, Simons JF, Simpson JW, Srinivasan M, Tartaro KR, Tomasz A, Vogt KA, Volkmer GA, Wang SH, Wang Y, Weiner MP, Yu P, Begley RF, Rothberg JM. 2005. Genome sequencing in microfabricated high-density picolitre reactors. Nature 437:376–380. http://dx.doi.org/10.1038/nature03959.
158. Rothberg JM, Hinz W, Rearick TM, Schultz J, Mileski W, Davey M, Leamon JH, Johnson K, Milgrew MJ, Edwards M, Hoon J, Simons JF, Marran D, Myers JW, Davidson JF, Branting A, Nobile JR, Puc BP, Light D, Clark TA, Huber M, Branciforte JT, Stoner IB, Cawley SE, Lyons M, Fu Y, Homer N, Sedova M, Miao X, Reed B, Sabina J, Feierstein E, Schorn M, Alanjary M, Dimalanta E, Dressman D, Kasinskas R, Sokolsky T, Fidanza JA, Namsaraev E, McKernan KJ, Williams A, Roth GT, Bustillo J. 2011. An integrated semiconductor device enabling non-optical genome sequencing. Nature 475:348–352. http://dx.doi.org/10.1038/nature10242.
159. Perkel J. 2011. Making contact with sequencing’s fourth generation. Biotechniques 50:93–95. http://dx.doi.org/10.2144/000113608.
160. Bragg LM, Stone G, Butler MK, Hugenholtz P, Tyson GW. 2013. Shining a light on dark sequencing: characterising errors in ion torrent PGM data. PLoS Comput. Biol. 9:e1003031. http://dx.doi.org/10.1371/journal.pcbi.1003031.
161. Campbell PJ, Morlock GP, Sikes RD, Dalton TL, Metchock B, Starks AM, Hooks DP, Cowan LS, Plikaytis BB, Posey JE. 2011. Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Myco-bacterium tuberculosis. Antimicrob. Agents Chemother. 55:2032–2041. http://dx.doi.org/10.1128/AAC.01550-10.
162. Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F, Allen J, Tahirli R, Blakemore R, Rustomjee R, Milovic A, Jones M, O’Brien SM, Persing DH, Ruesch-Gerdes S, Gotuzzo E, Rodrigues C, Alland D, Perkins MD. 2010. Rapid molecular detection of tuberculosis and rifampin resistance. N. Engl. J. Med. 363:1005–1015. http://dx.doi.org/10.1056/NEJMoa0907847.
163. Bravo LT, Tuohy MJ, Ang C, Destura RV, Mendoza M, Procop GW, Gordon SM, Hall GS, Shrestha NK. 2009. Pyrosequencing for rapid detection of Mycobacterium tuberculosis resistancetorifampin, isoniazid, and fluoroquinolones. J. Clin. Microbiol. 47:3985–3990. http://dx.doi.org/10.1128/JCM.01229-09.
164. Jureen P, Engstrand L, Eriksson S, Alderborn A, Krabbe M, Hoffner SE. 2006. Rapid detection of rifampin resistance in Mycobacterium tuberculosis by pyrosequencing technology. J. Clin. Microbiol. 44:1925–1929. http://dx.doi.org/10.1128/JCM.02210-05.
165. Maughan H, Wang PW, Diaz Caballero J, Fung P, Gong Y, Donaldson SL, Yuan L, Keshavjee S, Zhang Y, Yau YC, Waters VJ, Tullis DE, Hwang DM, Guttman DS. 2012. Analysis of the cystic fibrosis lung microbiota via serial Illumina sequencing of bacterial 16S rRNA hyper-variable regions. PLoS One 7:e45791. http://dx.doi.org/10.1371/journal.pone.0045791.
166. Mellmann A, Harmsen D, Cummings CA, Zentz EB, Leopold SR, Rico A, Prior K, Szczepanowski R, Ji Y, Zhang W, McLaughlin SF, Hen-khaus JK, Leopold B, Bielaszewska M, Prager R, Brzoska PM, Moore RL, Guenther S, Rothberg JM, Karch H. 2011. Prospective genomic characterization of the German enterohemorrhagic Escherichia coli O104:H4 outbreak by rapid next generation sequencing technology. PLoS One 6:e22751. http://dx.doi.org/10.1371/journal.pone.0022751.
167. Sherry NL, Porter JL, Seemann T, Watkins A, Stinear TP, Howden BP. 2013. Outbreak investigation using high-throughput genome sequencing within a diagnostic microbiology laboratory. J. Clin. Microbiol. 51: 1396–1401. http://dx.doi.org/10.1128/JCM.03332-12.
168. Hedskog C, Mild M, Jernberg J, Sherwood E, Bratt G, Leitner T, Lundeberg J, Andersson B, Albert J. 2010. Dynamics of HIV-1 quasi-species during antiviral treatment dissected using ultra-deep pyrose-quencing. PLoS One 5:e11345. http://dx.doi.org/10.1371/journal.pone.0011345.
169. Larsen BB, Chen L, Maust BS, Kim M, Zhao H, Deng W, Westfall D, Beck I, Frenkel LM, Mullins JI. 2013. Improved detection of rare HIV-1 variants using 454 pyrosequencing. PLoS One 8:e76502. http://dx.doi.org/10.1371/journal.pone.0076502.
170. Chang MW, Oliveira G, Yuan J, Okulicz JF, Levy S, Torbett BE. 2013. Rapid deep sequencing of patient-derived HIV with ion semiconductor technology. J. Virol. Methods 189:232–234. http://dx.doi.org/10.1016/j.jviromet.2013.01.019.
171. Palmer S, Kearney M, Maldarelli F, Halvas EK, Bixby CJ, Bazmi H, Rock D, Falloon J, Davey RT, Jr, Dewar RL, Metcalf JA, Hammer S, Mellors JW, Coffin JM. 2005. Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis. J. Clin. Microbiol. 43:406–413. http://dx.doi.org/10.1128/JCM.43.1.406-413.2005.
172. Hirsch MS, Gunthard HF, Schapiro JM, Brun-Vezinet F, Clotet B, Hammer SM, Johnson VA, Kuritzkes DR, Mellors JW, Pillay D, Yeni PG, Jacobsen DM, Richman DD. 2008. Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel. Clin. Infect. Dis. 47:266–285. http://dx.doi.org/10.1086/589297.
173. Li JZ, Paredes R, Ribaudo HJ, Svarovskaia ES, Metzner KJ, Kozal MJ, Hullsiek KH, Balduin M, Jakobsen MR, Geretti AM, Thiebaut R, Ostergaard L, Masquelier B, Johnson JA, Miller MD, Kuritzkes DR. 2011. Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis. JAMA. 305:1327–1335. http://dx.doi.org/10.1001/jama.2011.375.
174. Rego N, Bianchi S, Moreno P, Persson H, Kvist A, Pena A, Oppezzo P, Naya H, Rovira C, Dighiero G, Pritsch O. 2012. Search for an aetiological virus candidate in chronic lymphocytic leukaemia by extensive transcriptome analysis. Br. J. Haematol. 157:709–717. http://dx.doi.org/10.1111/j.1365-2141.2012.09116.x.
175. Lan J, Tai HC, Lee SW, Chen TJ, Huang HY, Li CF. 2014. Deficiency in expression and epigenetic DNA Methylationof ASS1 geneinnasopha-ryngeal carcinoma: negative prognostic impact and therapeutic relevance. Tumour Biol. 35:161–169. http://dx.doi.org/10.1007/s13277-013 -1020-8.
176. Leclerc D, Levesque N, Cao Y, Deng L, Wu Q., Powell J, Sapienza C, Rozen R. 2013. Genes with aberrant expression in murine preneoplastic intestine show epigenetic and expression changes in normal mucosa of colon cancer patients. Cancer Prev. Res. 6:1171–1181. http://dx.doi.org/10.1158/1940-6207.CAPR-13-0198.
177. Shendure J, Porreca GJ, Reppas NB, Lin X, McCutcheon JP, Rosen-baum AM, Wang MD, Zhang K, Mitra RD, Church GM. 2005. Accurate multiplex polony sequencing of an evolved bacterial genome. Sci. 309:1728–1732. http://dx.doi.org/10.1126/science.1117389.
178. Voelkerding KV, Dames SA, Durtschi JD. 2009. Next-generation sequencing: from basic research to diagnostics. Clin. Chem. 55:641–658. http://dx.doi.org/10.1373/clinchem.2008.112789.
179. Dooley KC. 2003. Tandem mass spectrometry in the clinical chemistry laboratory. Clin. Biochem. 36:471–481. http://dx.doi.org/10.1016/S0009 -9120(03)00105-X.
180. Sauer S, Kliem M. 2010. Mass spectrometry tools for the classification and identification of bacteria. Nat. Rev. Microbiol. 8:74–82. http://dx.doi.org/10.1038/nrmicro2243.
181. Yates JR, Ruse CI, Nakorchevsky A. 2009. Proteomics by mass spectrom-etry: approaches, advances, and applications. Annu. Rev. Biomed. Eng. 11: 49–79. http://dx.doi.org/10.1146/annurev-bioeng-061008-124934.
182. La Scola B. 2011. Intact cell MALDI-TOF mass spectrometry-based approaches for the diagnosis of bloodstream infections. Expert Rev. Mol. Diagn. 11:287–298.
183. Cherkaoui A, Hibbs J, Emonet S, Tangomo M, Girard M, Francois P, Schrenzel J. 2010. Comparison of two matrix-assisted laser desorption ionization–time of flight mass spectrometry methods with conventional phenotypic identification for routine identification of bacteria to the species level. J. Clin. Microbiol. 48:1169–1175. http://dx.doi.org/10.1128/JCM.01881-09.
184. Jamal WY, Shahin M, Rotimi VO. 2013. Comparison of two matrixassisted laser desorption/ionization-time of flight (MALDI-TOF) mass spectrometry methods and API 20AN for identification of clinically relevant anaerobic bacteria. J. Med. Microbiol. 62:540–544. http://dx.doi.org/10.1099/jmm.0.053256-0.
185. Marko DC, Saffert RT, Cunningham SA, Hyman J, Walsh J, Arbefe-ville S, Howard W, Pruessner J, Safwat N, Cockerill FR, Bossler AD, Patel R, Richter SS. 2012. Evaluation of the Bruker Biotyper and Vitek MS matrix-assisted laser desorption ionization–time of flight mass spec-trometry systems for identification of nonfermenting Gram-negative bacilli isolated from cultures from cystic fibrosis patients. J. Clin. Micro-biol. 50:2034–2039. http://dx.doi.org/10.1128/JCM.00330-12.
186. Martiny D, Busson L, Wybo I, El Haj RA, Dediste A, Vandenberg O. 2012. Comparison of the Microflex LT and Vitek MS systems for routine identification of bacteria by matrix-assisted laser desorption ionization–time of flight mass spectrometry. J. Clin. Microbiol. 50:1313–1325. http://dx.doi.org/10.1128/JCM.05971-11.
187. Rychert J, Burnham CA, Bythrow M, Garner OB, Ginocchio CC, Jennemann R, Lewinski M., Manji R, Mochon AB, Procop GW, Richter SS, Sercia L, Westblade LF, Ferraro MJ, Branda JA. 2013. Multicenter evaluation of the Vitek MS matrix-assisted laser desorption ionization–time of flight mass spectrometry system for identification of Gram-positive aerobic bacteria. J. Clin. Microbiol. 51:2225–2231. http://dx.doi.org/10.1128/JCM.00682-13.
188. Branda JA, Rychert J, Burnham CA, Bythrow M, Garner OB, Ginocchio CC, Jennemann R, Lewinski M., Manji R, Mochon AB, Procop GW, Richter SS, Sercia LF, Westblade LF, Ferraro MJ. 2014. Multicenter validation of the VITEK MS v2.0 MALDI-TOF mass spectrometry system for the identification of fastidious gram-negative bacteria. Diagn. Microbiol. Infect. Dis. 78:129–131. http://dx.doi.org/10.1016/j.diagmicrobio.2013.08.013.
189. Manji R, Bythrow M, Branda JA, Burnham CA, Ferraro MJ, Garner OB, Jennemann R, Lewinski M., Mochon AB, Procop GW, Richter SS, Rychert JA, Sercia L, Westblade LF, Ginocchio CC. 2014. Multi-center evaluation of the VITEK(R) MS system for mass spectrometric identification of non-Enterobacteriaceae Gram-negative bacilli. Eur. J. Clin. Microbiol. Infect. Dis. 33:337–346. http://dx.doi.org/10.1007/s10096-013-1961-2.
190. Garner O, Mochon A, Branda J, Burnham CA, Bythrow M, Ferraro M, Ginocchio C, Jennemann R, Manji R, Procop GW, Richter S, Rychert J, Sercia L, Westblade L, Lewinski M. 2014. Multi-centre evaluation of mass spectrometric identification of anaerobic bacteria using the VITEK(R) MS system. Clin. Microbiol. Infect. 20:335–339. http://dx.doi.org/10.1111/1469-0691.12317.
191. Benagli C, Rossi V, Dolina M, Tonolla M, Petrini O. 2011. Matrix-assisted laser desorption ionization-time of flight mass spectrometry for the identificationofclinically relevant bacteria. PLoS One 6:e16424. http://dx.doi.org/10.1371/journal.pone.0016424.
192. Saffert RT, Cunningham SA, Ihde SM, Jobe KE, Mandrekar J, Patel R. 2011. Comparison of Bruker Biotyper matrix-assisted laser desorption ionization-time of flight mass spectrometer to BD Phoenix automated microbiology system for identification of gram-negative bacilli. J. Clin. Microbiol. 49:887–892. http://dx.doi.org/10.1128/JCM.01890-10.
193. Tan KE, Ellis BC, Lee R, Stamper PD, Zhang SX, Carroll KC. 2012. Prospective evaluation of a matrix-assisted laser desorption ionization-time of flight mass spectrometry system in a hospital clinical microbiology laboratory for identificationofbacteria and yeasts:a bench-by-bench study for assessing the impact on time to identification and cost-effectiveness. J. Clin. Microbiol. 50:3301–3308. http://dx.doi.org/10.1128/JCM.01405-12.
194. Ferreira L, Sanchez-Juanes F, Gonzalez-Avila M, Cembrero-Fucinos D, Herrero-Hernandez A, Gonzalez-Buitrago JM, Munoz-Bellido JL. 2010. Direct identification ofurinary tract pathogens from urine samples by matrix-assisted laser desorption ionization-time of flight mass spec-trometry. J. Clin. Microbiol. 48:2110–2115. http://dx.doi.org/10.1128/JCM.02215-09.
195. Demarco ML, Burnham CA. 2014. Diafiltration MALDI-TOF mass spectrometry method for culture-independent detection and identification of pathogens directly from urine specimens. Am. J. Clin. Pathol. 141:204–212. http://dx.doi.org/10.1309/AJCPQYW3B6JLKILC.
196. Buchan BW, Riebe KM, Ledeboer NA. 2012. Comparison of the MALDI Biotyper system using Sepsityper specimen processing toroutine microbiological methods for identification of bacteria from positive blood culture bottles. J. Clin. Microbiol. 50:346–352. http://dx.doi.org/10.1128/JCM.05021-11.
197. Fothergill A, Kasinathan V, Hyman J, Walsh J, Drake T, Wang YF. 2013. Rapid identification of bacteria and yeasts from positive-blood-culture bottlesbyusingalysis-filtration method and matrix-assisted laser desorption ionization-time of flight mass spectrum analysis with the SARAMIS database. J. Clin. Microbiol. 51:805–809. http://dx.doi.org/10.1128/JCM.02326-12.
198. Chen JH, Ho PL, Kwan GS, She KK, Siu GK, Cheng VC, Yuen KY, Yam WC. 2013. Direct bacterial identification in positive blood cultures by use of two commercial matrix-assisted laser desorption ionization-time of flight mass spectrometry systems. J. Clin. Microbiol. 51:1733–1739. http://dx.doi.org/10.1128/JCM.03259-12.
199. Moussaoui W, Jaulhac B, Hoffmann AM, Ludes B, Kostrzewa M, Riegel P, Prevost G. 2010. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry identifies 90% of bacteria directly from blood culture vials. Clin. Microbiol. Infect. 16:1631–1638. http://dx.doi.org/10.1111/j.1469-0691.2010.03356.x.
200. Stevenson LG, Drake SK, Murray PR. 2010. Rapid identification of bacteria in positive blood culture broths by matrix-assisted laser desorp-tion ionization–time of flight mass spectrometry. J. Clin. Microbiol. 48: 444–447. http://dx.doi.org/10.1128/JCM.01541-09.
201. Wang XH, Zhang G, Fan YY, Yang X, Sui WJ, Lu XX. 2013. Direct identification of bacteria causing urinary tract infections by combining matrix-assisted laser desorption ionization-time offlight mass spectrom-etry with UF-1000i urine flow cytometry. J. Microbiol. Methods 92:231–235. http://dx.doi.org/10.1016/j.mimet.2012.12.016.
202. Huang AM, Newton D, Kunapuli A, Gandhi TN, Washer LL, Isip J, Collins CD, Nagel JL. 2013. Impact of rapid organism identification via matrix-assisted laser desorption ionization time-of-flight combined with antimicrobial stewardship team intervention in adult patients with bac-teremia and candidemia. Clin. Infect. Dis. 57:1237–1245. http://dx.doi.org/10.1093/cid/cit498.
203. Perez KK, Olsen RJ, Musick WL, Cernoch PL, Davis JR, Land GA, Peterson LE, Musser JM. 2013. Integrating rapid pathogen identification and antimicrobial stewardship significantly decreases hospital costs. Arch. Pathol. Lab. Med. 137:1247–1254. http://dx.doi.org/10.5858/arpa.2012-0651-OA.
204. Buchan BW, Ledeboer NA. 2013. Advances in identification of clinical yeast isolates by use of matrix-assisted laser desorption ionization–time of flight mass spectrometry. J. Clin. Microbiol. 51:1359–1366. http://dx.doi.org/10.1128/JCM.03105-12.
205. L’Ollivier C, Cassagne C, Normand AC, Bouchara JP, Contet-Audonneau N, Hendrickx M, Fourquet P, Coulibaly O, Piarroux R, Ranque S. 2013. A MALDI-TOF MS procedure for clinical dermato-phyte species identification in the routine laboratory. Med. Mycol. 51: 713–720. http://dx.doi.org/10.3109/13693786.2013.781691.
206. Ranque S, Normand AC, Cassagne C, Murat JB, Bourgeois N, Dalle F, Gari-Toussaint M, Fourquet P, Hendrickx M, Piarroux R. 2014. MALDI-TOF mass spectrometry identification of filamentous fungi in the clinical laboratory. Mycoses 57:135–140. http://dx.doi.org/10.1111/myc.12115.
207. Cassagne C, Ranque S, Normand AC, Fourquet P, Thiebault S, Pla-nard C, Hendrickx M, Piarroux R. 2011. Mould routine identification in the clinical laboratory by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. PLoS One 6:e28425. http://dx.doi.org/10.1371/journal.pone.0028425.
208. Buchan BW, Riebe KM, Timke M, Kostrzewa M, Ledeboer NA. 2014. Comparison of MALDI-TOF MS with HPLC and nucleic acid sequencing for the identification of Mycobacterium species in cultures using solid medium and broth. Am. J. Clin. Pathol. 141:25–34. http://dx.doi.org/10.1309/AJCPBPUBUDEW2OAG.
209. Balada-Llasat JM, Kamboj K, Pancholi P. 2013. Identification of my-cobacteria from solid and liquid media by matrix-assisted laser desorp-tion ionization–time of flight mass spectrometry in the clinical laboratory. J. Clin. Microbiol. 51:2875–2879. http://dx.doi.org/10.1128/JCM.00819-13.
210. Pignone M, Greth KM, Cooper J, Emerson D, Tang J. 2006. Identification of mycobacteria by matrix-assisted laser desorption ionization–time-of-flight mass spectrometry. J.Clin. Microbiol. 44:1963–1970. http://dx.doi.org/10.1128/JCM.01959-05.
211. Westblade LF, Jennemann R, Branda JA, Bythrow M, Ferraro MJ, Garner OB, Ginocchio CC, Lewinski M., Manji R, Mochon AB, Procop GW, Richter SS, Rychert JA, Sercia L, Burnham CA. 2013. Multicenter study evaluating the Vitek MS system for identification of medically important yeasts. J. Clin. Microbiol. 51:2267–2272. http://dx.doi.org/10.1128/JCM.00680-13.
212. Pence MA, McElvania Tekippe E, Wallace MA, Burnham CA. 7 May 2014. Comparison and optimization of two MALDI-TOF MS platforms for the identification of medically relevant yeast species. Eur. J. Clin. Microbiol. Infect. Dis. http://dx.doi.org/10.1007/s10096-014-2115-x.
213. Bader O, Weig M, Taverne-Ghadwal L, Lugert R, Gross U, Kuhns M. 2011. Improved clinical laboratory identification of human pathogenic yeasts by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin. Microbiol. Infect. 17:1359–1365. http://dx.doi.org/10.1111/j.1469-0691.2010.03398.x.
214. Dhiman N, Hall L, Wohlfiel SL, Buckwalter SP, Wengenack NL. 2011. Performance and cost analysis of matrix-assisted laser desorp-tion ionization-time of flight mass spectrometry for routine identification of yeast. J. Clin. Microbiol. 49:1614–1616. http://dx.doi.org/10.1128/JCM.02381-10.
215. Marklein G, Josten M, Klanke U, Muller E, Horre R, Maier T, Wenzel T, Kostrzewa M, Bierbaum G, Hoerauf A, Sahl HG. 2009. Matrix-assisted laser desorption ionization–time of flight mass spectrometry for fast and reliable identification of clinical yeast isolates. J. Clin. Microbiol. 47:2912–2917. http://dx.doi.org/10.1128/JCM.00389-09.
216. Stevenson LG, Drake SK, Shea YR, Zelazny AM, Murray PR. 2010. Evaluation of matrix-assisted laser desorption ionization–time of flight mass spectrometry for identification of clinically important yeast species. J. Clin. Microbiol. 48:3482–3486. http://dx.doi.org/10.1128/JCM.00687-09.
217. Mather CA, Rivera SF, Butler-Wu SM. 2014. Comparison of the Bruker Biotyper and Vitek MS matrix-assisted laser desorption ionization–time of flight mass spectrometry systems for identification of mycobacteria using simplified protein extraction protocols. J. Clin. Microbiol. 52:130–138. http://dx.doi.org/10.1128/JCM.01996-13.
218. Saleeb PG, Drake SK, Murray PR, Zelazny AM. 2011. Identification of mycobacteria in solid-culture media by matrix-assisted laser desorption ionization–time offlight mass spectrometry.J. Clin. Microbiol. 49:1790–1794. http://dx.doi.org/10.1128/JCM.02135-10.
219. Lotz A, Ferroni A, Beretti JL, Dauphin B, Carbonnelle E, Guet-Revillet H, Veziris N, Heym B, Jarlier V, Gaillard JL, Pierre-Audigier C, Frapy E, Berche P, Nassif X, Bille E. 2010. Rapid identification of mycobac-terial whole cells in solid and liquid culture media by matrix-assisted laser desorption ionization–time of flight mass spectrometry. J. Clin. Microbiol. 48:4481–4486. http://dx.doi.org/10.1128/JCM.01397-10.
220. Balazova T, Makovcova J, Sedo O, Slany M, Faldyna M, Zdrahal Z. 2014. The influence of culture conditions on the identification of Myco-bacterium species by MALDI-TOF MS profiling. FEMS Microbiol. Lett. 353:77–84. http://dx.doi.org/10.1111/1574-6968.12408.
221. Sparbier K, Schubert S, Weller U, Boogen C, Kostrzewa M. 2012. Matrix-assisted laser desorption ionization–time of flight mass spec-trometry-based functional assay for rapid detection of resistance against beta-lactam antibiotics. J. Clin. Microbiol. 50:927–937. http://dx.doi.org/10.1128/JCM.05737-11.
222. Hrabak J, Studentova V, Walkova R, Zemlickova H, Jakubu V, Chu-dackova E, Gniadkowski M, Pfeifer Y, Perry JD, Wilkinson K, Bergerova T. 2012. Detection of NDM-1, VIM-1, KPC, OXA-48, and OXA-162 carbapenemases by matrix-assisted laser desorption ioniza-tion-time of flight mass spectrometry. J. Clin. Microbiol. 50:2441–2443. http://dx.doi.org/10.1128/JCM.01002-12.
223. Sparbier K, Lange C, Jung J, Wieser A, Schubert S, Kostrzewa M. 2013. MALDI Biotyper-based rapid resistance detection by stable-isotope labeling. J. Clin. Microbiol. 51:3741–3748. http://dx.doi.org/10.1128/JCM.01536-13.
224. Metzgar D, Baynes D, Myers CA, Kammerer P, Unabia M, Faix DJ, Blair PJ. 2010. Initial identification and characterization of an emerging zoonotic influenza virus prior to pandemic spread. J. Clin. Microbiol. 48:4228–4234. http://dx.doi.org/10.1128/JCM.01336-10.
225. Sampath R, Russell KL, Massire C, Eshoo MW, Harpin V, Blyn LB, Melton R, Ivy C, Pennella T, Li F, Levene H, Hall TA, Libby B, Fan N, Walcott DJ, Ranken R, Pear M, Schink A, Gutierrez J, Drader J, Moore D, Metzgar D, Addington L, Rothman R, Gaydos CA, Yang S, St George K, Fuschino ME, Dean AB, Stallknecht DE, Goekjian G, Yingst S, Monteville M, Saad MD, Whitehouse CA, Baldwin C, Rudnick KH, Hofstadler SA, Lemon SM, Ecker DJ. 2007. Global surveillance of emerging influenza virus genotypes by mass spectrometry. PLoS One 2:e489. http://dx.doi.org/10.1371/journal.pone.0000489.
226. Jacob D, Sauer U, Housley R, Washington C, Sannes-Lowery K, Ecker DJ, Sampath R, Grunow R. 2012. Rapid and high-throughput detection of highly pathogenic bacteria by Ibis PLEX-ID technology. PLoS One 7:e39928. http://dx.doi.org/10.1371/journal.pone.0039928.
227. Kaleta EJ, Clark AE, Cherkaoui A, Wysocki VH, Ingram EL, Schrenzel J, Wolk DM. 2011. Comparative analysis of PCR-electrospray ioniza-tion/mass spectrometry (MS) and MALDI-TOF/MS for the identification of bacteria and yeast from positive blood culture bottles. Clin. Chem. 57:1057–1067. http://dx.doi.org/10.1373/clinchem.2011.161968.
228. Kaleta EJ, Clark AE, Johnson DR, Gamage DC, Wysocki VH, Cherka-oui A, Schrenzel J, Wolk DM. 2011. Use of PCR coupled with electro-spray ionization mass spectrometry for rapid identification of bacterial and yeast bloodstream pathogens from blood culture bottles. J. Clin. Microbiol. 49:345–353. http://dx.doi.org/10.1128/JCM.00936-10.
229. Pierce SE, Bell RL, Hellberg RS, Cheng CM, Chen KS, Williams-Hill DM, Martin WB, Allard MW. 2012. Detection and identification of Salmonella enterica, Escherichia coli, and Shigella spp. via PCR-electrospray ionization mass spectrometry: isolate testing and analysis of food samples. Appl. Environ. Microbiol. 78:8403–8411. http://dx.doi.org/10.1128/AEM.02272-12.
230. Sampath R, Mulholland N, Blyn LB, Massire C, Whitehouse CA, Waybright N, Harter C, Bogan J, Miranda MS, Smith D, Baldwin C, Wolcott M, Norwood D, Kreft R, Frinder M, Lovari R, Yasuda I, Matthews H, Toleno D, Housley R, Duncan D, Li F, Warren R, Eshoo MW, Hall TA, Hofstadler SA, Ecker DJ. 2012. Comprehensive bio-threat cluster identification by PCR/electrospray-ionization mass spec-trometry. PLoS One 7:e36528. http://dx.doi.org/10.1371/journal.pone.0036528.
231. Mengelle C, Mansuy JM, Da Silva I, Guerin JL, Izopet J. 2013. Evaluation of a polymerase chain reaction-electrospray ionization time-of-flight mass spectrometry for the detection and subtyping of influenza viruses in respiratory specimens. J. Clin. Virol. 57:222–226. http://dx.doi.org/10.1016/j.jcv.2013.03.004.
232. Tang YW, Lowery KS, Valsamakis A, Schaefer VC, Chappell JD, White-Abell J, Quinn CD, Li H, Washington CA, Cromwell J, Gia-manco CM, Forman M, Holden J, Rothman RE, Parker ML, Orten-berg EV, Zhang L, Lin YL, Gaydos CA. 2013. Clinical accuracy of a PLEX-ID flu device for simultaneous detection and identification of influenza viruses A and B. J. Clin. Microbiol. 51:40–45. http://dx.doi.org/10.1128/JCM.01978-12.
233. Trampuz A, Piper KE, Jacobson MJ, Hanssen AD, Unni KK, Osmon DR, Mandrekar JN, Cockerill FR, Steckelberg JM, Greenleaf JF, Patel R. 2007. Sonication of removed hip and knee prostheses for diagnosis of infection. N. Engl. J. Med. 357:654–663. http://dx.doi.org/10.1056/NEJMoa061588.
234. Achermann Y, Vogt M, Leunig M, Wust J, Trampuz A. 2010. Improved diagnosis of periprosthetic joint infection by multiplex PCR of sonication fluid from removed implants. J. Clin. Microbiol. 48:1208–1214. http://dx.doi.org/10.1128/JCM.00006-10.
235. Butler-Wu SM, Burns EM, Pottinger PS, Magaret AS, Rakeman JL, Matsen FAIII, Cookson BT. 2011. Optimization of periprosthetic culture for diagnosis of Propionibacterium acnes prosthetic joint infection. J. Clin. Microbiol. 49:2490–2495. http://dx.doi.org/10.1128/JCM.00450-11.
236. Jacovides CL, Kreft R, Adeli B, Hozack B, Ehrlich GD, Parvizi J. 2012. Successful identification of pathogens by polymerase chain reaction (PCR)-based electron spray ionization time-of-flight mass spectrometry (ESI-TOF-MS) inculture-negative periprosthetic joint infection. J. Bone Joint Surg. Am. 94:2247–2254. http://dx.doi.org/10.2106/JBJS.L.00210.
237. Greenwood-Quaintance KE, Uhl JR, Hanssen AD, Sampath R, Man-drekar JN, Patel R. 2014. Diagnosis of prosthetic joint infection by use of PCR-electrospray ionization mass spectrometry. J. Clin. Microbiol. 52: 642–649. http://dx.doi.org/10.1128/JCM.03217-13.
238. Simner PJ, Uhl JR, Hall L, Weber MM, Walchak RC, Buckwalter S, Wengenack NL. 2013. Broad-range direct detection and identification of fungi by use of the PLEX-ID PCR-electrospray ionization mass spec-trometry system. J. Clin. Microbiol. 51:1699–1706. http://dx.doi.org/10.1128/JCM.03282-12.
239. Greub G, Prod’hom G. 2011. Automation in clinical bacteriology: what system to choose? Clin. Microbiol. Infect. 17:655–660. http://dx.doi.org/10.1111/j.1469-0691.2011.03513.x.
240. Novak SM, Marlowe EM. 2013. Automation in the clinical microbiology laboratory. Clin. Lab. Med. 33:567–588. http://dx.doi.org/10.1016/j.cll.2013.03.002.
241. Bourbeau PP, Ledeboer NA. 2013. Automation in clinical microbiology. J. Clin. Microbiol. 51:1658–1665. http://dx.doi.org/10.1128/JCM.00301-13.
242. Burnham CA, Dunne WM, Jr, Greub G, Novak SM, Patel R. 2013. Automation in the clinical microbiology laboratory. Clin. Chem. 59: 1696–1702. http://dx.doi.org/10.1373/clinchem.2012.201038.
243. Mischnik A, Mieth M, Busch CJ, Hofer S, Zimmermann S. 2012. First evaluation of automated specimen inoculation for wound swab samples by use of the Previ Isola system compared to manual inoculation in a routine laboratory: finding a cost-effective and accurate approach. J. Clin. Microbiol. 50:2732–2736. http://dx.doi.org/10.1128/JCM.05501-11.
244. Bourbeau PP, Swartz BL. 2009. First evaluation of the WASP, a new automated microbiology plating instrument. J. Clin. Microbiol. 47: 1101–1106. http://dx.doi.org/10.1128/JCM.01963-08.
245. Glasson JH, Guthrie LH, Nielsen DJ, Bethell FA. 2008. Evaluation of an automated instrument for inoculating and spreading samples onto agar plates. J. Clin. Microbiol. 46:1281–1284. http://dx.doi.org/10.1128/JCM.01687-07.
246. Tilton RC, Ryan RW. 1978. Evaluation of an automated agar plate streaker. J. Clin. Microbiol. 7:298–304.
247. Van Horn KG, Audette CD, Sebeck D, Tucker KA. 2008. Comparison of the Copan ESwab system with two Amies agar swab transport systems for maintenance ofmicroorganism viability.J. Clin. Microbiol. 46:1655–1658. http://dx.doi.org/10.1128/JCM.02047-07.
248. Rivers CA, Schwebke JR. 2008. Viability of Trichomonas vaginalis in Co-pan universal transport medium and eSwab transport medium. J. Clin. Mi-crobiol. 46:3134–3155. http://dx.doi.org/10.1128/JCM.00841-08.
249. Nys S, Vijgen S, Magerman K, Cartuyvels R. 2010. Comparison of Copan eSwab with the Copan Venturi Transystem for the quantitative survival of Escherichia coli, Streptococcus agalactiae and Candida albicans. Eur. J. Clin. Microbiol. Infect. Dis. 29:453–456. http://dx.doi.org/10.1007/s10096-010-0883-5.
250. Saegeman V, Flamaing J, Muller J, Peetermans WE, Stuyck J, Verhae-gen J. 2011. Clinical evaluation of the Copan ESwab for methicillin-resistant Staphylococcus aureus detection and culture of wounds. Eur. J. Clin. Microbiol. Infect. Dis. 30:943–949. http://dx.doi.org/10.1007/s10096-011-1178-1.
251. Smismans A, Verhaegen J, Schuermans A, Frans J. 2009. Evaluation of the Copan ESwab transport system for the detection of methicillin-resistant Staphylococcus aureus: a laboratory and clinical study. Diagn. Microbiol. Infect. Dis. 65:108–111. http://dx.doi.org/10.1016/j.diagmicrobio.2009.06.015.
252. Indevuyst C, Beuselinck K, Lagrou K. 2012. Eswab flocked swabs unfit for viral culture. J. Clin. Virol. 55:282–283. http://dx.doi.org/10.1016/j.jcv.2012.07.006.
253. Mutters NT, Hodiamont CJ, de Jong MD, Overmeijer HP, van den Boogaard M, Visser CE. 2014. Performance of Kiestra total laboratory automation combined with MS in clinical microbiology practice. Ann. Lab. Med. 34:111–117. http://dx.doi.org/10.3343/alm.2014.34.2.111.
254. Matthews S, Deutekom J. 2011. The future of diagnostic bacteriology. Clin. Microbiol. Infect. 17:651–654. http://dx.doi.org/10.1111/j.1469 -0691.2011.03512.x.
255. Bentley N, Farrington M, Doughton R, Pearce D. 2011. Automating the bacteriology laboratory, abstr P 1792. Abstr. Eur. Congr. Clin. Micro-biol. Infect. Dis., Milan, Italy.
256. Humphrey G, Malone C, Gough H, Awadel-Kariem M. 2011. Experience with KIESTRA’s Total Lab Automation solutiion to meet teh challenge ofuniversal MRSA screening for Lister Hospital,alargeUK distract general hospital, abstr P 1793. Abstr. Eur. Congr. Clin. Microbiol. Infect. Dis., Milan, Italy.
257. Ford A. 2013. Molecular testing platforms a land of plenty. CAP Today 27:22–42.
258. Laurent C, Bogaerts P, Schoevaerdts D, Denis O, Deplano A, Swine C, Struelens MJ, Glupczynski Y. 2010. Evaluation of the Xpert MRSA assay for rapid detection of methicillin-resistant Staphylococcus aureus from nares swabs of geriatric hospitalized patients and failure to detect a specific SCCmec type IV variant. Eur. J. Clin. Microbiol. Infect. Dis. 29:995–1002. http://dx.doi.org/10.1007/s10096-010-0958-3.
259. Wolk DM, Struelens MJ, Pancholi P, Davis T, Della-Latta P, Fuller D, Picton E, Dickenson R, Denis O, Johnson D, Chapin K. 2009. Rapid detection of Staphylococcus aureus and methicillin-resistant S. aureus (MRSA)inwound specimens and blood cultures: multicenter preclinical evaluationof the Cepheid Xpert MRSA/SA skin and soft tissue and blood culture assays. J. Clin. Microbiol. 47:823–826. http://dx.doi.org/10.1128/JCM.01884-08.
260. Spencer DH, Sellenriek P, Burnham CA. 2011. Validation and implementation of the GeneXpert MRSA/SA blood culture assay in a pediatric setting. Am. J. Clin. Pathol. 136:690–694. http://dx.doi.org/10.1309/AJCP07UGYOKBVVNC.
261. Glenn TC. 2011. Field guide to next-generation DNA sequencers. Mol. Ecol. Resources 11:759–769. http://dx.doi.org/10.1111/j.1755-0998.2011.03024.x.